TEVA - 2Q12 US Copaxone sales reported today by Teva were $701M up from $617M and in today's call the Dr. Levin said it is still growing in unit terms.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.